Glukagon-like Peptide 1- (7-37)

<strong>Glukagon-like Peptide 1-(7-37)</strong>_x000D_ <strong>Catalog number:</strong> B2019182_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> RT_x000D_ <strong>Keywords:</strong> 1450806-98-0 | AKOS025142102 | GLP-1 (7-37) | DTXSID50147676 | GLP-1(7-37) Acetate | GLP-1(7-37) acetate(106612-94-6 free base) | AC-8923 | F92802 | GLP-1 (7-37) peptide | CID 16133830_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Mohiuddin MS, Himeno T, Inoue R, Miura-Yura E, Yamada Y, Nakai-Shimoda H, Asano S, Kato M, Motegi M, Kondo M, Seino Y, Tsunekawa S, Kato Y, Suzuki A, Naruse K, Kato K, Nakamura J, Kamiya H. Glucagon-Like Peptide-1 Receptor Agonist Protects Dorsal Root Ganglion Neurons against Oxidative Insult J Diabetes Res. 2019 Feb 21;2019:9426014._x000D_ 2: Wootten D, Simms J, Koole C, Woodman OL, Summers RJ, Christopoulos A, Sexton PM. Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids J Pharmacol Exp Ther. 2011 Feb;336(2):540-50._x000D_ 3: Moellmann J, Klinkhammer BM, Onstein J, St√∂hr R, Jankowski V, Jankowski J, Lebherz C, Tacke F, Marx N, Boor P, Lehrke M. Glucagon-Like Peptide 1 and Its Cleavage Products Are Renoprotective in Murine Diabetic Nephropathy Diabetes. 2018 Nov;67(11):2410-2419._x000D_ 4: Dillon JS, Tanizawa Y, Wheeler MB, Leng XH, Ligon BB, Rabin DU, Yoo-Warren H, Permutt MA, Boyd AE 3rd. Cloning and functional expression of the human glucagon-like peptide-1 (GLP-1) receptor Endocrinology. 1993 Oct;133(4):1907-10._x000D_ 5: Zhao L, Ye H, Li D, Lao X, Li J, Wang Z, Xiao L, Wu Z, Huang J. Glucagon-like peptide-1(1-37) can enhance blood glucose homeostasis in mice Regul Pept. 2012 Oct 10;178(1-3):1-5._x000D_ 6: Sun X, Zhang Z, Liu M, Zhang P, Nie L, Liu Y, Chen Y, Xu F, Liu Z, Zeng Y. Small-molecule albumin ligand modification to enhance the anti-diabetic ability of GLP-1 derivatives Biomed Pharmacother. 2022 Apr;148:112722._x000D_ 7: Rye Underwood C, M√∏ller Knudsen S, Schjellerup Wulff B, Br√§uner-Osborne H, Lau J, Knudsen LB, Peters GH, Reedtz-Runge S. Transmembrane Œ±-helix 2 and 7 are important for small molecule-mediated activation of the GLP-1 receptor Pharmacology. 2011;88(5-6):340-8._x000D_ 8: Koole C, Wootten D, Simms J, Miller LJ, Christopoulos A, Sexton PM. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery J Pharmacol Exp Ther. 2015 Apr;353(1):52-63._x000D_ 9: Alavi SE, Cabot PJ, Raza A, Moyle PM. Developing GLP-1 Conjugated Self-Assembling Nanofibers Using Copper-Catalyzed Alkyne-Azide Cycloaddition and Evaluation of Their Biological Activity Bioconjug Chem. 2021 Apr 21;32(4):810-820._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/15183905">10: Sarrauste de Menthi√®re C, Chavanieu A, Grassy G, Dalle S, Salazar G, Kervran A, Pfeiffer B, Renard P, Delagrange P, Manechez D, Bakes D, Ktorza A, Calas B. Structural requirements of the N-terminal region of GLP-1-[7-37]-NH2 for receptor interaction and cAMP production Eur J Med Chem. 2004 Jun;39(6):473-80. </a>_x000D_ _x000D_ <strong>Products Related to Glukagon-like Peptide 1-(7-37) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>